On account of the clinical picture and absence of a BCR::ABL1 fusion, she was diagnosed with a Philadelphia-negative myeloproliferative neoplasm and treated accordingly with hydroxycarbamide. Here, ABL1 is linked to myeloproliferative neoplasm.